Literature DB >> 6941419

Is dopamine an inhibitory modulator of gastrointestinal motility?

J A Schuurkes, J M Van Nueten.   

Abstract

The effects of dopamine were studied on the isolated guinea-pig stomach preparation, including the duodenal bulb. Phasic activity: intra-arterially administered dopamine (0.25 mg/l) reduced phasic activity and blocked antro-duodenal coordination. The selective dopamine-antagonist, domperidone, increased phasic amplitude and improved antro-duodenal coordination. Tonic activity: gastric relaxation induced by equi-active concentrations of dopamine (0.25 mg/l, i.a.) and noradrenaline (0.04 mg/l, i.a.) could be antagonized by domperidone and prazosin; domperidone being more effective against dopamine and prazosin against noradrenaline. Our results support the hypothesis that dopamine acts as an inhibitory neuromodulator. The actions of dopamine in decreasing spontaneous activity and in inducing relaxation could set the stage for duodenal-gastric reflux.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941419

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  8 in total

1.  Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa.

Authors:  D Deleu; G Ebinger; Y Michotte
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease.

Authors:  T Thomaides; T Karapanayiotides; Y Zoukos; C Haeropoulos; E Kerezoudi; N Demacopoulos; G Floodas; E Papageorgiou; F Armakola; Y Thomopoulos; I Zaloni
Journal:  J Neurol       Date:  2005-04-04       Impact factor: 4.849

3.  Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.

Authors:  Hong Can Zhu; Jing Zhao; Chang Yue Luo; Qian Qian Li
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

Review 4.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

5.  Domperidone and levodopa in Parkinson's disease.

Authors:  J S Shindler; G T Finnerty; K Towlson; A L Dolan; C L Davies; J D Parkes
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 6.  Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

7.  Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy.

Authors:  M Horowitz; P E Harding; B E Chatterton; P J Collins; D J Shearman
Journal:  Dig Dis Sci       Date:  1985-01       Impact factor: 3.199

8.  Effect of domperidone and dopamine on colonic motor activity in patients with the irritable bowel syndrome.

Authors:  G A Lanfranchi; G Bazzocchi; F Fois; C Brignola; M Campieri; B Menni
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.